RDY Historical Income Statement

RDY Stock

USD 12.81 0.05 0.39%

Historical analysis of Dr Reddys income statement accounts such as Research Development of 27.6 B, Cost Of Revenue of 139.5 B, Income Before Tax of 86.8 B or Net Income Applicable To Common Shares of 54.4 B can show how well Dr Reddys Laboratories performed in making a profits. Evaluating Dr Reddys income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Dr Reddys's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Dr Reddys Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Dr Reddys Laboratories is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

About RDY Income Statement Analysis

Dr Reddys Laboratories Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Dr Reddys shareholders. The income statement also shows RDY investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Dr Reddys Income Statement Chart

At this time, Dr Reddys' Depreciation And Amortization is fairly stable compared to the past year. Other Operating Expenses is likely to rise to about 255.3 B in 2025, whereas Selling General Administrative is likely to drop slightly above 66 B in 2025.

Total Revenue Gross Profit Operating Income Research Development

Total Revenue

Total revenue comprises all receipts Dr Reddys Laboratories generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Dr Reddys Laboratories minus its cost of goods sold. It is profit before Dr Reddys operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Operating Income

Operating Income is the amount of profit realized from Dr Reddys Laboratories operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Dr Reddys Laboratories is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most accounts from Dr Reddys' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Dr Reddys Laboratories current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

	2022	2023	2024	2025 (projected)
Gross Profit	203.0B	163.6B	188.1B	197.6B
Total Revenue	245.9B	279.2B	321.0B	337.1B

Gross Profit Total Revenue

Dr Reddys income statement Correlations

	Interest Expense	Total Revenue	Gross Profit	Operating Income	Research Development	Cost Of Revenue	Income Before Tax	Net Income	Income Tax Expense	Depreciation And Amortization	Selling General Administrative	Other Operating Expenses	Ebit	Ebitda	Total Operating Expenses	Total Other Income Expense Net	Net Income From Continuing Ops	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Selling And Marketing Expenses
Interest Expense		0.89	0.86	0.83	0.74	0.8	0.92	0.93	0.84	0.62	0.64	0.86	0.88	0.88	0.82	0.32	0.78	0.75	0.0	0.06	0.74	-0.66
Total Revenue	0.89		0.96	0.9	0.91	0.9	0.93	0.93	0.88	0.77	0.83	0.99	0.94	0.96	0.96	0.33	0.77	0.78	-0.08	0.24	0.77	-0.66
Gross Profit	0.86	0.96		0.97	0.85	0.74	0.93	0.93	0.9	0.75	0.78	0.91	0.93	0.95	0.98	0.36	0.77	0.81	-0.22	0.04	0.71	-0.59
Operating Income	0.83	0.9	0.97		0.71	0.63	0.93	0.92	0.89	0.67	0.8	0.81	0.93	0.94	0.91	0.32	0.82	0.84	-0.19	-0.01	0.7	-0.56
Research Development	0.74	0.91	0.85	0.71		0.84	0.78	0.78	0.73	0.77	0.63	0.93	0.78	0.82	0.92	0.3	0.51	0.58	-0.18	0.17	0.63	-0.56
Cost Of Revenue	0.8	0.9	0.74	0.63	0.84		0.78	0.78	0.71	0.67	0.77	0.95	0.81	0.83	0.76	0.24	0.63	0.59	0.15	0.52	0.74	-0.66
Income Before Tax	0.92	0.93	0.93	0.93	0.78	0.78		0.99	0.96	0.76	0.77	0.88	0.95	0.97	0.88	0.47	0.88	0.92	-0.02	0.11	0.82	-0.72
Net Income	0.93	0.93	0.93	0.92	0.78	0.78	0.99		0.93	0.71	0.76	0.88	0.97	0.97	0.87	0.39	0.89	0.89	-0.01	0.07	0.83	-0.73
Income Tax Expense	0.84	0.88	0.9	0.89	0.73	0.71	0.96	0.93		0.86	0.72	0.83	0.86	0.9	0.86	0.66	0.82	0.97	-0.01	0.17	0.75	-0.66
Depreciation And Amortization	0.62	0.77	0.75	0.67	0.77	0.67	0.76	0.71	0.86		0.59	0.77	0.64	0.74	0.77	0.67	0.57	0.78	0.01	0.3	0.58	-0.54
Selling General Administrative	0.64	0.83	0.78	0.8	0.63	0.77	0.77	0.76	0.72	0.59		0.81	0.86	0.86	0.74	0.17	0.76	0.68	0.02	0.48	0.74	-0.47
Other Operating Expenses	0.86	0.99	0.91	0.81	0.93	0.95	0.88	0.88	0.83	0.77	0.81		0.9	0.92	0.93	0.32	0.71	0.71	-0.05	0.33	0.75	-0.66
Ebit	0.88	0.94	0.93	0.93	0.78	0.81	0.95	0.97	0.86	0.64	0.86	0.9		0.99	0.87	0.21	0.86	0.81	-0.05	0.13	0.83	-0.69
Ebitda	0.88	0.96	0.95	0.94	0.82	0.83	0.97	0.97	0.9	0.74	0.86	0.92	0.99		0.91	0.3	0.85	0.85	-0.04	0.16	0.83	-0.7
Total Operating Expenses	0.82	0.96	0.98	0.91	0.92	0.76	0.88	0.87	0.86	0.77	0.74	0.93	0.87	0.91		0.36	0.69	0.73	-0.27	0.07	0.66	-0.55
Total Other Income Expense Net	0.32	0.33	0.36	0.32	0.3	0.24	0.47	0.39	0.66	0.67	0.17	0.32	0.21	0.3	0.36		0.37	0.69	0.02	0.23	0.3	-0.3
Net Income From Continuing Ops	0.78	0.77	0.77	0.82	0.51	0.63	0.88	0.89	0.82	0.57	0.76	0.71	0.86	0.85	0.69	0.37		0.86	-0.04	0.09	0.82	-0.71
Tax Provision	0.75	0.78	0.81	0.84	0.58	0.59	0.92	0.89	0.97	0.78	0.68	0.71	0.81	0.85	0.73	0.69	0.86		0.04	0.15	0.74	-0.66
Interest Income	0.0	-0.08	-0.22	-0.19	-0.18	0.15	-0.02	-0.01	-0.01	0.01	0.02	-0.05	-0.05	-0.04	-0.27	0.02	-0.04	0.04		0.44	0.07	-0.09
Net Interest Income	0.06	0.24	0.04	-0.01	0.17	0.52	0.11	0.07	0.17	0.3	0.48	0.33	0.13	0.16	0.07	0.23	0.09	0.15	0.44		0.23	-0.12
Reconciled Depreciation	0.74	0.77	0.71	0.7	0.63	0.74	0.82	0.83	0.75	0.58	0.74	0.75	0.83	0.83	0.66	0.3	0.82	0.74	0.07	0.23		-0.58
Selling And Marketing Expenses	-0.66	-0.66	-0.59	-0.56	-0.56	-0.66	-0.72	-0.73	-0.66	-0.54	-0.47	-0.66	-0.69	-0.7	-0.55	-0.3	-0.71	-0.66	-0.09	-0.12	-0.58

Click cells to compare fundamentals

Dr Reddys Account Relationship Matchups

Dr Reddys income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Interest Expense	970M	958M	1.4B	1.7B	2.0B	2.1B
Total Revenue	189.7B	214.4B	245.9B	279.2B	321.0B	337.1B
Gross Profit	103.1B	113.8B	203.0B	163.6B	188.1B	197.6B
Operating Income	36.1B	40.8B	96.3B	67.7B	77.9B	81.8B
Research Development	16.5B	17.5B	19.4B	22.9B	26.3B	27.6B
Cost Of Revenue	86.6B	100.6B	42.9B	115.6B	132.9B	139.5B
Income Before Tax	28.3B	32.3B	60.5B	71.9B	82.7B	86.8B
Net Income Applicable To Common Shares	19.5B	19.1B	23.6B	45.1B	51.8B	54.4B
Net Income	17.2B	23.6B	45.1B	55.7B	64.0B	67.2B
Income Tax Expense	9.2B	8.7B	15.4B	16.2B	18.6B	19.5B
Depreciation And Amortization	12.8B	11.8B	12.6B	14.8B	17.1B	17.9B
Selling General Administrative	54.6B	62.1B	46.5B	77.2B	69.5B	66.0B
Other Operating Expenses	156.8B	177.4B	160.5B	211.4B	243.2B	255.3B
Ebit	32.9B	35.9B	61.8B	73.6B	84.6B	88.8B
Ebitda	45.7B	47.7B	74.4B	88.4B	101.7B	106.8B
Total Operating Expenses	70.1B	76.8B	117.6B	95.9B	110.3B	115.8B
Total Other Income Expense Net	4.0B	2.8B	3.3B	4.1B	4.8B	5.0B
Net Income From Continuing Ops	19.1B	23.6B	45.1B	55.7B	64.0B	67.2B
Tax Provision	9.2B	8.7B	15.4B	16.2B	18.6B	19.5B
Extraordinary Items	(3M)	41M	313M	44M	50.6M	53.1M
Interest Income	1.7B	3.1B	1.1B	2.3B	2.6B	2.2B
Net Interest Income	1.7B	2.1B	(1.4B)	567M	652.1M	327.0M
Reconciled Depreciation	12.8B	11.8B	12.5B	14.8B	17.1B	13.9B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

RDY Historical Income Statement

About RDY Income Statement Analysis

Dr Reddys Income Statement Chart

Total Revenue

Gross Profit

Operating Income

Dr Reddys income statement Correlations

Dr Reddys Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Dr Reddys income statement Accounts

Also Currently Popular

Additional Tools for RDY Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 0.99	Total Revenue
Net Income	+ 0.99	Income Before Tax
Ebitda	+ 0.99	Ebit
Total Operating Expenses	+ 0.98	Gross Profit
Operating Income	+ 0.97	Gross Profit
Ebitda	+ 0.97	Income Before Tax

Selling And Marketing Expenses	- 0.73	Net Income
Selling And Marketing Expenses	- 0.72	Income Before Tax
Selling And Marketing Expenses	- 0.71	Net Income From Continuing Ops
Selling And Marketing Expenses	- 0.7	Ebitda
Selling And Marketing Expenses	- 0.69	Ebit
Selling And Marketing Expenses	- 0.66	Tax Provision